Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice

Cardiac damage is the major limiting factor for the clinical use of doxorubicin (DOX). Preclinical studies indicate that inflammatory effects may be involved in DOX-induced cardiotoxicity. Nɛ-(carboxymethyl) lysine (CML) is suggested to be generated subsequent to oxidative stress, including inflammation. Therefore, the aim of this study was to investigate whether CML increased in the heart after DOX and whether anti-inflammatory agents reduced this effect in addition to their possible protection on DOX-induced cardiotoxicity. These effects were compared with those of the potential cardioprotector 7-monohydroxyethylrutoside (monoHER)

Viscous approximation of quasistatic evolutions for a coupled elastoplastic-damage model

Employing the technique of vanishing viscosity and time rescaling, we show the existence of quasistatic evolutions for elastoplastic materials with incomplete damage affecting both the elastic tensor and the plastic yield surface, in a softening framework and in small strain assumptions